Pulling SEC filings + quote and writing the call…
Pulling SEC filings + quote and writing the call…

TAKEDA PHARMACEUTICAL CO LTD
Next earnings Jul 28, 2026 · consensus $53.06 EPS, $1.17T rev
Mixed signals in the latest filings.
TAKEDA PHARMACEUTICAL CO LTD shows limited reported revenue.
Sources: SEC EDGAR (CIK 0001395064, latest IRANNOTICE filed 2026-06-17) · EODHD · as of 6/22/2026, 1:53:16 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
€15/mo · cancel anytime
No income data filed.
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosed under the STOCK Act
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
1482 tracked peers · median
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
| 2026-04-27 | Weber Christophe Pierre President and CEO | Award | 78.9K | |
| 2026-04-27 | Weber Christophe Pierre President and CEO | Award | 165K | |
| 2026-04-27 | Furuta Milano Chief Financial Officer | Award | 7.80K | |
| 2026-04-27 | Plump Andrew Stewart President, R&D | Award | 212K | |
| 2026-04-27 | Ricci Gabriele Chief Data & Tech. Officer | Award | 35.0K | |
| 2026-04-27 | Bitetti Teresa Marie President, OBU | Award | 65.0K | |
| 2026-04-27 | Duprey Lauren Rusckowski Chief Transformation Officer | Award | 60.0K | |
| 2026-04-27 | Kim Julie So-Young CEO - Elect | Award | 105K | |
| 2026-04-27 | Platford Giles Richard President, IBU | Award | 72.1K |
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.